Terraflora Daily Care and Gastrointestinal Health
ConditionGastrointestinal
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25+
SponsorOvationLab
About this trial
A 12-week, randomized, double-blind, placebo-controlled clinical trial will be conducted evaluating the effectiveness of Enviromedica - Terraflora Daily Care on markers of gastrointestinal function and symptoms.
Eligibility criteria
Qualifiers
Adult males or females age ≥ 25 years
Ability to read and speak English
Dysbiosis (≥3 on GA-Map Dysbiosis Score) on a stool test (GI360 Profile, Doctor's Data, St. Charles, Illinois)
Disqualifiers
Daily use within the past month of any probiotic or prebiotic supplement
Current diagnosis of inflammatory bowel disease, including Crohn's or ulcerative colitis
Current daily usage of non-steroidal anti-inflammatory drugs (NSAID), proton pump inhibitors (PPI), or antibiotic medications
Current daily tobacco smoker
Trial design
Treatments tested in this trial
- Synbiotic Dietary Supplement
- Placebo
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov